Viracta Therapeutics, Inc., a precision oncology company targeting virus-associated malignancies, announced that company management is scheduled to present at the Jefferies Healthcare Conference on Thursday, June 9, 2022, at 1:30 p.m. EDT.
June 1, 2022
· 1 min read